Wockhardt Regenerative Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 252.15%
- Profit Growth -954.42%
- Ebitda -1470.10%
- Net Worth -1024.61%
- Total Assets 92.01%
About Wockhardt Regenerative
Wockhardt Regenerative Private Limited (WRPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2020 (Four years and two months 28 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Zahabiya Khorakiwala and Vijay Sharma serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100MH2020PTC350811
- Company No.
350811
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Wockhardt Regenerative?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Zahabiya Khorakiwala  | Director | 26-Nov-2020 | Current |
| Vijay Sharma | Director | 26-Nov-2020 | Current |
Financial Performance of Wockhardt Regenerative.
Wockhardt Regenerative Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 252.15% increase. The company also saw a substantial fall in profitability, with a 954.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1024.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wockhardt Regenerative?
In 2023, Wockhardt Regenerative had a public holding of 0.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wockhardt Hospitals LimitedZahabiya Khorakiwala is a mutual person
Wockhardt LimitedZahabiya Khorakiwala is a mutual person
- Wockhardt Bionova Limited
Zahabiya Khorakiwala is a mutual person
Rpg Life Sciences LimitedZahabiya Khorakiwala is a mutual person
Hz Trading & Services LlpZahabiya Khorakiwala is a mutual person
- Hnz Trading & Services Llp
Zahabiya Khorakiwala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wockhardt Regenerative?
Unlock and access historical data on people associated with Wockhardt Regenerative, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wockhardt Regenerative, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Regenerative's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
